A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants
Clinical trial NCT03285620 · COMPLETED
Trial details
- NCT number
- NCT03285620
- Sponsor
- Alios Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2018-11-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.